NASDAQ: DBTX

US-based biopharmaceutical company Regeneron Pharmaceuticals Inc., (NASDAQ: REGN) has announced the acquisition of fellow US firm Decibel Therapeutics Inc., (NASDAQ: DBTX), a partner since 2017 specializing in gene therapies for hearing loss. Regeneron is paying an initial USD 4 per Decibel share, valuing the transaction at approximately USD 109 million,…